Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study (Frontiers in Oncology, (2025), 15, (1465256), 10.3389/fonc.2025.1465256)

  • Eunju Shin
  • , Seung Il Kim
  • , Min Ho Park
  • , Hyun Ah Kim
  • , Yongsik Jung
  • , Jai Min Ryu
  • , Eun Hwa Park
  • , Sung Yong Kim
  • , Eun Gyeong Lee
  • , Min Hyuk Lee
  • , Jung Ho Park
  • , Seock Ah Im
  • , Soong June Bae
  • , Su Hwan Kang
  • , Woo Sung Lim
  • , Hyun Jo Youn
  • , Heung Kyu Park
  • , Kyong Hwa Park
  • , Tae Hyun Kim
  • , Shin Young Park
  • Cheol Wan Lim, Geum Hee Kwak, Chanheun Park, Hyuk Jae Shin, Young Bum Yoo, Sun Hee Kang, Bong Kyun Kim, Hee Jeong Kim

Research output: Contribution to journalComment/debate

Abstract

Breast Cancer An incorrect Funding statement was provided. The correct Funding statement reads: “This research was supported by a grant of the Patient-Centered Clinical Research Coordinating Center (PACEN) funded by Ministry of Health & Welfare, Republic of Korea (grant number: RS-2024-00396822) and the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (grant number: 2020IF0004).” The original version of this article has been updated.

Original languageEnglish
Article number1729229
JournalFrontiers in Oncology
Volume15
DOIs
StatePublished - 2025

Bibliographical note

Publisher Copyright:
Copyright © 2025 Shin, Kim, Park, Kim, Jung, Ryu, Park, Kim, Lee, Lee, Park, Im, Bae, Kang, Lim, Youn, Park, Park, Kim, Park, Lim, Kwak, Park, Shin, Yoo, Kang, Kim and Kim.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • bone health
  • breast cancer
  • chemotherapy
  • ovarian function
  • premenopausal women

Fingerprint

Dive into the research topics of 'Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study (Frontiers in Oncology, (2025), 15, (1465256), 10.3389/fonc.2025.1465256)'. Together they form a unique fingerprint.

Cite this